Come see us at the Advanced Therapies Congress, March 18-19, 2025, in London!
Meet with INOVOTION’s Sales Director Arnaud Peyronnier and Candice Chrétien (MabDesign’ stand 33), at Europe’s largest cell and gene therapy conference, where 2,500+ attendees, 300+ expert speakers, and 150+ exhibitors will come together to discuss the latest breakthroughs in cell therapy, gene therapy, regenerative medicine, and tissue engineering.
We are excited to be part of this cutting-edge event, where top biotech and pharma leaders, researchers, and innovators gather to shape the future of advanced therapies.
As a pioneer for in vivo preclinical testing in oncology, we provide a fast, reliable, and cost-effective platform to accelerate your drug development process. Our unique NAMs CAM model (ChorioAllantoic Membrane assay) offers:
- Rapid, predictive results to streamline your preclinical testing
- A powerful alternative to traditional in vivo models, reducing costs and ethical concerns
- Validated applications in oncology, cell therapies, and biomaterials
If you’re developing innovative anticancer therapies and need efficient preclinical evaluation, visit our stand 33 to see how INOVOTIONcan support your projects! We’ll be happy to discuss your needs and potential collaborations.
Many thanks to MabDesign, Lyonbiopôle Auvergne-Rhône-Alpes, and the Région Auvergne-Rhône-Alpes region for providing us space on their stand !!!
We look forward to seeing you in London and shaping the future of advanced therapies together!
For more information about our ground-breaking CAM model: contact us
